Symphogen strikes potential billion-dollar deal with Baxalta
Relaterede artikler
Symphogen raises EUR 67.5 million
For abonnenter
Drug giant cancels partnership with Symphogen
For abonnenter
Drejer: Sad to see Santaris go, but…
For abonnenter
En del af Watch Medier
For abonnenter
For abonnenter
For abonnenter
Vær på forkant med udviklingen. Få den nyeste viden fra branchen med vores nyhedsbrev.
NyhedsbrevsvilkårFor abonnenter
For abonnenter
For abonnenter
QP delegate Biologics, CMC
Governmental Public Affairs & Communications Head
Healthcare Compliance Senior Specialist (Associated Director), Ascendis Pharma
Head of OTC Product Development
Principal Bioinformatic Scientist, Antibody Technology
QA Manager GMP
Skilled Process Specialist for managing logistic and production processes in SAP
Global Head of Rewards
Head of Quality Assurance
ESG Officer
Senior Legal Counsel
QA/RA Specialist, Patient Handling Division
Environmental Monitoring Professional
Senior Consultant / Project Manager - Life Science (R&D & Clinical)
Principal Quality Assurance Professional – Combination Products
Material Scientist and Coordinator
Investor Relations Manager
Produktionskemiker
Quality Engineer for Production
Business Development Manager
Senior Laboratory Technician (Laborant) – Biophysical Protein Characterization
Principal Research Scientist within Biophysical characterisation and pre-formulation